A few thoughts:
1. We have got addicted to crack. Not in
A few thoughts:
1. We have got addicted to crack. Not in the drug sense but in the addictive sense that was presented by Nader. He was very open and talkative on most any points. We had grown addicted to the next big thing and feverishly pontificated on what would happen. Like the soap operas of the 70's and 80's, we couldn't wait for the next revelation. NOW.....s...i..l..e...n...c..e..... and no more CRACK. The withdrawals are violent and were unexpected. Now we go cold turkey for a while wreathing, cursing and secretly wishing that we had Nader back just one last broadcast in order to calm our curiosity fix. Ain't gonna happen! Weather it's a NDA or just business as usual, the company decided not to go the old route and we have to get use to the new norm. It's a rude awakening, but in the long run, more advantageous for the company and therefore more beneficial to us longs as there is no false hopes, past deadlines or progress reports for the shorts to hang their hat on. The time it takes to put together a presentation and the past reports were very time consuming. Now this time is being used for something more constructive. Is the next report negative or positive? We shall see.
Positive: Much of the risk in the stock price has been taken out.
Positive:The 700mg numbers should be tallied by now or very soon and most hypothesis is that they should be as good or better than the 350 mg numbers.
Positive:The loan commitment payment was delayed and usually a statement is made as to penalties or such if loan can not be met. There was no statement, just an extension. If I'm a creditor and the company has no way to pay, I start seizing assets to be first in line if there is a line. Although his is not always the case as they could give them more time because they have a better chance of collecting, but ask yourself why? most reasons are positive.
2 Positive 1 Negative: CEO not in place at a crucial time in company's history. There are only a few reasons for this at this particular time.
A: Negative: fired for Disagreement in principal and or objectives with presiding board
B: Positive: Prearrangement with merger/buyout company so they can put their CEO in place
C: Positive: Decided to find a CEO with more pharma experience and now became the time because of calendar events about to happen that a more specifically pharma experienced CEO can guide the company through.
Positive: As Evil stated :If Cytodyn was facing its own End Times, it wouldn't be making hires, seeking a CEO, continuing trials, and sitting on results we're all pretty damn sure are excellent.
Multiple other upcoming possible events have been chronologically listed by others and we don't need many to put us in a comfortable position going forward. So on this Valentines Day, I wish for all a love and may the only flutters be in your heart. GLTA
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Top 5 Most Recently Viewed Articles
Natus Medical's New Integration for Enhanced User Experience Natus Medical Incorporated has recently introduced a noteworthy development within its product line. The integration of the InVisus Pro Neuromuscular Ultrasound system with Natus Elite Software is a significant enhancement for EMG system users. This innovation enables a seamless connection between the InVisus...
Continue Reading
It’s a 10® Haircare Unveils Dynamic Advertising Strategy It's a 10® Haircare, a renowned professional haircare brand, has taken an exciting leap into innovative advertising with their recent Uber campaign. This unique initiative not only elevates the brand's visibility but also connects directly with beauty enthusiasts who frequent major retail outlets. Engaging...
Continue Reading
Cohen & Steers Quality Income Realty Fund Overview In this article, we dive into the details regarding the distribution sources for Cohen & Steers Quality Income Realty Fund, Inc. (RQI). This information is crucial for current shareholders as it directly impacts their investment decisions and overall understanding of the fund's financial performance. Understanding Managed...
Continue Reading
Understanding the Success of ActivatedYou Morning Complete Maggie Q's ActivatedYou has recently celebrated a remarkable achievement, hitting over 5 million units sold of their flagship product, Morning Complete. This milestone is a testament to the product's appeal and the effectiveness that many consumers have experienced. What is ActivatedYou Morning Complete? Morning...
Continue Reading
Transforming Pediatric Pain Management with Integrative Approaches The Stad Center for Pediatric Pain, Palliative and Integrative Medicine at UCSF Benioff Children's Hospitals has recently launched a groundbreaking facility. This innovative center blends Eastern and Western medicine to provide a comprehensive care approach for children experiencing pain and serious...
Continue Reading